Macquarie Value Fund Class A (DDVAX) is an open-end mutual fund that seeks long-term capital appreciation as its primary objective, with current income as a secondary goal; it invests primarily in dividend-paying stocks of large-capitalization companies (generally those with market capitalizations of $5 billion or greater at the time of purchase) and income-producing securities convertible into common stocks, including common stocks, preferred stocks, and convertible securities of U.S. issuers believed to offer long-term appreciation potential. The fund maintains a portfolio concentrated in sectors such as technology, healthcare, energy, and utilities, with top holdings including CDW Corp, Baxter International, Teledyne Technologies, Chevron, and Duke Energy; it features a front-end sales load of 5.75%, a net expense ratio of 0.97-0.98%, and an annual portfolio turnover rate of approximately 30-31%, distributing dividends and capital gains annually. Managed by Delaware Management Company, a division of Macquarie Investment Management (formerly Delaware Investments, acquired by Macquarie Group in 2010 and rebranded in 2017), the fund operates in the large-value segment of the U.S. equity market, targeting institutional and retail investors seeking value-oriented exposure to undervalued large-cap equities. Headquartered in Philadelphia, Pennsylvania, the fund traces its inception to September 14, 1998, with total assets under management around $258-2.2 billion across share classes as of late 2025. In a significant recent development, Nomura Holdings announced its acquisition of Macquarie's U.S. and European public asset management business—including DDVAX—in April 2025, leading to the fund's rebranding under Nomura as Nomura Value Fund Class A while retaining its investment strategy and management continuity. This transaction builds on Macquarie's legacy integration of Delaware Investments and reflects ongoing portfolio adjustments, such as sales of CVS and Honeywell positions in Q1 2025 amid market rotations, with the fund delivering competitive performance in the large-value category during Q3 2025.